U.S. Industrials Stock News

In late July 2026, DexCom, Inc. reported second-quarter results showing revenue of US$1,308.4 million and net income of US$249.1 million, and raised its full-year 2026 revenue guidance to US$5.18 billion–US$5.25 billion alongside higher margin expectations. The company highlighted rapid progress in securing coverage for type 2 diabetes patients not using insulin, advancing next-generation CGM sensors, and expanding internationally, reinforcing the importance of this broader metabolic health...

First Mid Bancshares stock has delivered a strong 84.4% return over the past three years, yet the valuation checks send a mixed message. The Excess Returns intrinsic value estimate points to meaningful upside, while earnings-based multiples look closer to fair. Over the past 3 years, First Mid Bancshares has returned 84.4%, which puts extra focus on whether the current price still leaves room for further value to be realised. Stronger recent earnings and revenue have supported sentiment...

Cullen/Frost Bankers, Inc. recently reported second-quarter 2026 results, with net interest income rising to US$447.73 million and net income to US$172.06 million, alongside slightly lower net charge-offs of US$9.53 million and board approval of common and preferred dividends payable on September 15, 2026. The combination of higher earnings, improved credit costs and continued cash returns to both common and preferred shareholders has strengthened the perception of Cullen/Frost’s operating...

International Business Machines (IBM) has been hit by weaker consulting and hardware sales in its preliminary second quarter, prompting lower full year revenue guidance and renewed scrutiny of how its quantum ambitions relate to the stock. See our latest analysis for International Business Machines. Against this backdrop of softer consulting and hardware trends, IBM's share price has fallen 21.9% over the past month and is down 23.3% year to date. However, the 3 year total shareholder return...

In the past quarter, Olin Corporation reported second-quarter 2026 sales of US$1,741.9 million, a slight year-over-year dip, while net loss widened to US$13.3 million as basic and diluted loss per share from continuing operations increased to US$0.12. Despite relatively stable revenue, Olin’s results highlighted how operational disruptions, such as the Freeport VCM outage, and continued losses are weighing on overall profitability across its portfolio. We’ll now examine how these loss-making...

Ituran Location and Control (ITRN) drew fresh investor attention after Vulcan Value Partners highlighted the stock in its Q2 2026 letter, citing what it described as strong Q1 results and contributions from long-term agreements with Stellantis, Renault, and BMW. See our latest analysis for Ituran Location and Control. Despite the latest Q1 update and the Vulcan Value Partners endorsement, Ituran Location and Control’s recent 30 day share price return is down 9.35%, while the year to date...

Glacier Bancorp (GBCI) has drawn fresh attention after reporting second quarter 2026 results, with higher net interest income and net income, alongside an increase in net charge-offs tied to overdrafts and loans. See our latest analysis for Glacier Bancorp. Glacier Bancorp's mixed recent share price performance, with a 1-day share price return of 0.65% but a 30-day share price return down 6.56%, contrasts with a stronger 1-year total shareholder return of 18.27%. This indicates that longer...

In the second quarter of 2026, Knowles Corporation reported higher sales and earnings compared with a year earlier, issued revenue and EPS guidance for the third quarter, and completed a multi‑year share repurchase program totaling 15,638,913 shares for US$294.07 million. Together, the improved profitability and ongoing capital return through buybacks highlight how Knowles is pairing earnings growth with an actively managed share base. We’ll now examine how Knowles’ stronger quarterly...

In late July 2026, Prosperity Bancshares, Inc. reported higher second-quarter and year-to-date earnings, modest net charge-offs of US$2.2 million, completion of a US$70.75 million share repurchase program, and affirmed a US$0.60 quarterly dividend payable on October 1, 2026. Management also highlighted continued discussions around future bank acquisitions while prioritizing the integration of three recently acquired banks, underscoring both growth ambitions and execution risk. We’ll now...

ICU Medical (ICUI) is in focus after US regulators published enforcement reports on voluntary Class II recalls of its Plum Duo and Plum Solo infusion pumps, citing a software issue affecting displayed dosing volumes. See our latest analysis for ICU Medical. The US Food and Drug Administration recall news lands against a backdrop of strong recent momentum in ICU Medical's share price, with a 30 day share price return of 13.51% and a 1 year total shareholder return of 32.27%, even as the 5 year...

Bank of N.T. Butterfield & Son has delivered a very strong 5 year return while the valuation checks still flag the stock as screening cheap on several measures. After that kind of run, investors are asking whether the current price still leaves room for a reasonable margin of safety. Over the past 5 years, Bank of N.T. Butterfield & Son has returned about 130%, which puts fresh focus on whether the current share price already reflects that value creation. The planned acquisition of CIBC...

Alibaba Group Holding (NYSE:BABA) is back in focus after reports of a major cloud deal supplying Moonshot AI with computing power equivalent to about 20,000 Nvidia chips. This development is drawing investor attention to its AI exposure. See our latest analysis for Alibaba Group Holding. Alibaba Group Holding's share price has reacted strongly to the Moonshot AI headlines, with a 1-day share price return of 5.10% and a 30-day share price return of 24.76%. However, the year to date share price...

Hilltop Holdings (HTH) is back in focus after a busy July, with fresh quarterly results, a higher dividend, additional buyback capacity, and a closely watched shareholder vote drawing new attention to the stock. See our latest analysis for Hilltop Holdings. At a share price of $39.44, Hilltop Holdings has built steady momentum, with a year to date share price return of 16.34% and a 1 year total shareholder return of 36.27%. This points to improving sentiment around earnings, buybacks, and the...

AirJoule Technologies Corporation announced that its AirJoule Core atmospheric water generation system has been deployed at GE Vernova’s Advanced Research Center Frontier Campus in Niskayuna, New York, where it now operates as a live showcase producing pure distilled water from air for visiting customers and partners. This installation deepens the 50/50 joint venture between AirJoule and GE Vernova by giving industrial and data center stakeholders direct exposure to AirJoule’s sorption-based...

Nuclear energy stocks are back in focus as investors look for power sources that are less tied to short term swings in fossil fuel prices and geopolitics. With inflation readings mixed across regions and energy driven price risks still on the radar, many are rethinking how they get exposure to long term electricity demand. The Nuclear Energy Stocks screener helps you quickly filter the sector, from uranium suppliers to reactor operators, so you can focus on liquid, listed companies rather...

Confusing signals from Federal Reserve Chair Kevin Warsh and a 5.23% yield on the 30 year U.S. Treasury have pushed interest rate risk back to the top of your watchlist. Long duration bond ETFs like TLT are feeling the pressure, while shorter term exposure such as IEI is drawing more attention as investors reassess where they want interest rate risk. This article examines how that backdrop connects to short duration fixed income themes and highlights three stocks tied to this news that could...

Life Time Group Holdings, Inc. reported stronger results for the quarter and six months ended June 30, 2026, with revenue rising to US$866.00 million and net income to US$101.36 million in the quarter, while also raising full-year 2026 revenue and net income guidance. The company is pairing this earnings momentum with an accelerated rollout of 14 largely large-format clubs in 2026, nearly doubling new-club square footage versus recent years and underscoring its push toward premium,...

Fresh scrutiny of Allient (ALNT) has been triggered by reports of declining sales and earnings per share over the past two years, along with persistently low returns on capital that are shaping the current investment debate. See our latest analysis for Allient. Despite the pressure on Allient’s fundamentals, the stock has kept strong momentum, with a year to date share price return of 57.36% and a 1 year total shareholder return of 130.59%, even after an 11.33% decline over the past month. If...

In late July 2026, Applied Materials gained investor attention after peer Lam Research reported record quarterly revenue and stronger guidance, prompting expectations that sector-wide demand for semiconductor equipment linked to AI infrastructure remains robust. The reaction highlights how closely investors tie Applied Materials’ prospects to broader wafer-fab equipment spending trends and read-throughs from key peers’ results. Next, we’ll examine how Lam Research’s stronger outlook, and its...

Travelers Companies expansion and recent bond issuance Travelers Companies (TRV) recently completed the nationwide rollout of its Travelers Synergy product liability coverage for life sciences firms, while also issuing callable senior unsecured fixed rate notes due 2031 totaling about US$750 million. See our latest analysis for Travelers Companies. At a share price of US$374.36, Travelers Companies has had a mixed few days, with the 1-day share price return declining 0.43% and the 7-day share...

In late July 2026, Wave Life Sciences reported Q2 2026 results showing sales of US$2.27 million versus US$8.70 million a year earlier, with net loss widening to US$69.36 million and basic loss per share from continuing operations at US$0.34. Despite weaker quarterly revenue, the company highlighted progress in its RNAi and RNA editing programs, including positive data for obesity candidate WVE-007 and preparations for an FDA meeting on a potential accelerated approval pathway for AATD...

International Seaways stock has logged very strong returns over the past few years, and after that run the current checks suggest it no longer looks obviously cheap on valuation. Over the last 5 years, International Seaways has delivered a very large total return of about 8.6x, which sets a high bar for any further share price gains to be justified by fundamentals. Future cash flows and earnings can benefit if the company maintains capital discipline and steady fleet utilization, while any...

In the second quarter of 2026, Axogen reported sales of US$69.73 million, up from US$56.66 million a year earlier, but moved from a net income of US$0.579 million to a net loss of US$1.52 million, with both basic and diluted loss per share from continuing operations at US$0.03. Despite higher losses for both the quarter and first half of 2026, Axogen raised its full-year 2026 revenue guidance to at least US$279 million, highlighting management’s increased confidence in the company’s top-line...

Revolution Medicines (RVMD) is back in focus after the FDA accepted its New Drug Application for daraxonrasib in previously treated metastatic pancreatic ductal adenocarcinoma, following Phase 3 RASolute 302 survival and quality of life data. See our latest analysis for Revolution Medicines. At a share price of US$187.53, Revolution Medicines has seen the share price rise 34.45% over the past 90 days and 137.32% year to date, with a 1 year total shareholder return above 400%. This suggests...